Literature DB >> 33521659

B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?

Puja Mehta1,2, Joanna C Porter1, Rachel C Chambers1, David A Isenberg2, Venkat Reddy2.   

Abstract

Entities:  

Year:  2020        PMID： 33521659      PMCID： PMC7836835          DOI： 10.1016/S2665-9913(20)30270-8

Source DB:  PubMed          Journal:  Lancet Rheumatol        ISSN： 2665-9913


× No keyword cloud information.
  5 in total

1.  Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia.

Authors:  Philippe Guilpain; Clément Le Bihan; Vincent Foulongne; Patrice Taourel; Nathalie Pansu; Alexandre Thibault Jacques Maria; Boris Jung; Romaric Larcher; Kada Klouche; Vincent Le Moing
Journal:  Ann Rheum Dis       Date:  2020-04-20       Impact factor: 19.103

2.  Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?

Authors:  Margherita Giannini; Mickael Ohana; Benoit Nespola; Giovanni Zanframundo; Bernard Geny; Alain Meyer
Journal:  Eur Respir J       Date:  2020-07-06       Impact factor: 16.671

3.  Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.

Authors:  Milena Gianfrancesco; Kimme L Hyrich; Jinoos Yazdany; Pedro M Machado; Philip C Robinson; Sarah Al-Adely; Loreto Carmona; Maria I Danila; Laure Gossec; Zara Izadi; Lindsay Jacobsohn; Patricia Katz; Saskia Lawson-Tovey; Elsa F Mateus; Stephanie Rush; Gabriela Schmajuk; Julia Simard; Anja Strangfeld; Laura Trupin; Katherine D Wysham; Suleman Bhana; Wendy Costello; Rebecca Grainger; Jonathan S Hausmann; Jean W Liew; Emily Sirotich; Paul Sufka; Zachary S Wallace
Journal:  Ann Rheum Dis       Date:  2020-05-29       Impact factor: 19.103

4.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

5.  Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.

Authors:  Yan Zhang; Meng Xiao; Shulan Zhang; Peng Xia; Wei Cao; Wei Jiang; Huan Chen; Xin Ding; Hua Zhao; Hongmin Zhang; Chunyao Wang; Jing Zhao; Xuefeng Sun; Ran Tian; Wei Wu; Dong Wu; Jie Ma; Yu Chen; Dong Zhang; Jing Xie; Xiaowei Yan; Xiang Zhou; Zhengyin Liu; Jinglan Wang; Bin Du; Yan Qin; Peng Gao; Xuzhen Qin; Yingchun Xu; Wen Zhang; Taisheng Li; Fengchun Zhang; Yongqiang Zhao; Yongzhe Li; Shuyang Zhang
Journal:  N Engl J Med       Date:  2020-04-08       Impact factor: 91.245
  5 in total
  21 in total

1.  Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience.

Authors:  Hakan Apaydin; Abdulsamet Erden; Serdar C Güven; Berkan Armağan; Özlem Karakaş; Bahar Özdemir; Bünyamin Polat; Mehmet Akif Eksin; Ahmet Omma; Orhan Kucuksahin
Journal:  Future Virol       Date:  2022-06-15       Impact factor: 3.015

2.  Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosis.

Authors:  Derek Chan; Sabina Karimi; George Follows; Nicholas Torpey; Ondrej Suchanek
Journal:  CEN Case Rep       Date:  2022-06-22

3.  Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: a tailored approach.

Authors:  Alessandra D'Abramo; Serena Vita; Gaetano Maffongelli; Andrea Mariano; Chiara Agrati; Concetta Castilletti; Delia Goletti; Giuseppe Ippolito; Emanuele Nicastri
Journal:  Int J Infect Dis       Date:  2021-04-23       Impact factor: 3.623

Review 4.  COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?

Authors:  Bahar Özdemir; Abdulsamet Erden; Serdar Can Güven; Berkan Armagan; Hakan Apaydin; Özlem Karakas; Ahmet Gokhan Akdag; İhsan Ates; Orhan Kucuksahin; Ahmet Omma
Journal:  Rheumatol Int       Date:  2021-05-25       Impact factor: 2.631

Review 5.  [The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].

Authors:  Tobias Monschein; Tobias Zrzavy; Micha Löbermann; Alexander Winkelmann; Thomas Berger; Paulus Rommer; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nervenarzt       Date:  2021-07-07       Impact factor: 1.297

6.  COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.

Authors:  Jérôme Avouac; Elodie Drumez; Eric Hachulla; Raphaèle Seror; Sophie Georgin-Lavialle; Soumaya El Mahou; Edouard Pertuiset; Thao Pham; Hubert Marotte; Amélie Servettaz; Fanny Domont; Pascal Chazerain; Mathilde Devaux; Pascal Claudepierre; Vincent Langlois; Arsène Mekinian; Alexandre Thibault Jacques Maria; Béatrice Banneville; Bruno Fautrel; Jacques Pouchot; Thierry Thomas; René-Marc Flipo; Christophe Richez
Journal:  Lancet Rheumatol       Date:  2021-03-25

7.  Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey.

Authors:  Chirag Rajkumar Kopp; Gsrsnk Naidu; Durga Prasanna Misra; Prateek Deo; Roopesh Sai Jakulla; Kavita Makan; Ajesh Maharaj; Vikas Agarwal; Aman Sharma
Journal:  Rheumatol Int       Date:  2021-08-24       Impact factor: 2.631

Review 8.  Managing rheumatoid arthritis during COVID-19.

Authors:  Rashmi Roongta; Alakendu Ghosh
Journal:  Clin Rheumatol       Date:  2020-09-06       Impact factor: 2.980

Review 9.  There are similarities between rheumatic disease with lung involvement and COVID-19 pneumonia.

Authors:  Joseph Williamson; Louisa Black; Anna Black; Gouri Koduri; Clive Kelly
Journal:  Ir J Med Sci       Date:  2021-02-10       Impact factor: 2.089

Review 10.  COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review.

Authors:  Alicia Rodriguez-Pla; Holenarasipur R Vikram; Vanood Khalid; Lewis J Wesselius
Journal:  Rheumatol Int       Date:  2021-06-06       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.